Geneva, June 20 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000161-87-Outside-EU/EEA) titled 'Resolution of Sickle Cell Leg Ulcers with Voxelotor (RESOLVE)' on June 13.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: yes Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: yes Other: no Number of treatment arms in the trial: 2
Primary Sponsor: Pfizer Inc.
Condition:
The treatment of leg ulcers in participants with sickle cell disease (SCD)
Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Intervention...